MiR-218-5p inhibits glioma progression by targeting CKLF-like MARVEL transmembrane domain-containing 3. Li X, Lu T, Wang T, Zhuo J, et al. BMC Cancer 2026 Jan 12. doi: 10.1186/s12885-026-15544.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Lu T, Wang T, Zhuo J, et al. MiR-218-5p inhibits glioma progression by targeting CKLF-like MARVEL transmembrane domain-containing 3. BMC Cancer 2026 Jan 12. doi: 10.1186/s12885-026-15544.
PMID: 41527058